Evidence map›Paper›PMID 27729528›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms.

Timothy Alexander Hore, Ferdinand von Meyenn, Mirunalini Ravichandran, Martin Bachman, Gabriella Ficz, David Oxley, Fátima Santos, Shankar Balasubramanian, Tomasz P Jurkowski, Wolf Reik

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 163 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Cell identity and 5-hydroxymethylcytosine.Epigenetics & chromatin · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Oxidative stress-mediated apoptosis via theFrontiers in pediatrics · 2025
    Article
  15. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Micronutrient regulation of the DNA methylome.Frontiers in epigenetics and epigenomics · 2024
    Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Timothy Alexander HoreEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom; Department of Anatomy, University of Otago, Dunedin 9016, New Zealand; tim.hore@otago.ac.nz tomasz.jurkowski@ibc.uni-stuttgart.de wolf.reik@babraham.ac.uk.ORCID 0000-0002-6735-225X
Ferdinand von MeyennEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.
Mirunalini RavichandranInstitute of Biochemistry, University of Stuttgart, 70569 Stuttgart, Germany.
Martin BachmanDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.ORCID 0000-0003-3903-6492
Gabriella FiczBarts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
David OxleyMass Spectrometry Facility, Babraham Institute, Cambridge CB22 3AT, United Kingdom.
Fátima SantosEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.
Shankar BalasubramanianDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, United Kingdom; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom.
Tomasz P JurkowskiInstitute of Biochemistry, University of Stuttgart, 70569 Stuttgart, Germany; tim.hore@otago.ac.nz tomasz.jurkowski@ibc.uni-stuttgart.de wolf.reik@babraham.ac.uk.
Wolf ReikEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom tim.hore@otago.ac.nz tomasz.jurkowski@ibc.uni-stuttgart.de wolf.reik@babraham.ac.uk.
Babraham Institute · GBUniversity of Cambridge · GBUniversity of Stuttgart · DEQueen Mary University of London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Epigenetic memory, in particular DNA methylation, is established during development in differentiating cells and must be erased to create naïve (induced) pluripotent stem cells. The ten-eleven translocation (TET) enzymes can catalyze the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and further oxidized derivatives, thereby actively removing this memory. Nevertheless, the mechanism by which the TET enzymes are regulated, and the extent to which they can be manipulated, are poorly understood. Here we report that retinoic acid (RA) or retinol (vitamin A) and ascorbate (vitamin C) act as modulators of TET levels and activity. RA or retinol enhances 5hmC production in naïve embryonic stem cells by activation of TET2 and TET3 transcription, whereas ascorbate potentiates TET activity and 5hmC production through enhanced Fe

Indexed as

5-MethylcytosineAnimalsAscorbic AcidCell DifferentiationDioxygenasesDNA-Binding ProteinsDNA MethylationEpigenesis, GeneticHumansInduced Pluripotent Stem CellsMiceProto-Oncogene ProteinsRegenerative MedicineTretinoinVitamin A5-MethylcytosineAscorbic AcidDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsTET2 protein, humanTET3 protein, humanTretinoinVitamin ADNA methylationepigenetic memorynaive pluripotencyTETvitamin A/C

Identifiers

PMID27729528
PMCPMC5086989
OpenAlexW2531164083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.